Dave Rosa
2023
In 2023, Dave Rosa earned a total compensation of $989.6K as Chief Executive Officer and President at NEUROONE MEDICAL TECHNOLOGIES Corp, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $253,328 |
|---|---|
| Option Awards | $84,090 |
| Salary | $506,655 |
| Stock Awards | $145,485 |
| Total | $989,558 |
Rosa received $506.7K in salary, accounting for 51% of the total pay in 2023.
Rosa also received $253.3K in non-equity incentive plan, $84.1K in option awards and $145.5K in stock awards.
Rankings
In 2023, Dave Rosa's compensation ranked 1,091st out of 2,238 executives tracked by ExecPay. In other words, Rosa earned more than 51.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,091 out of 2,238 | 51st |
Division Manufacturing | 645 out of 1,216 | 47th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 84 out of 188 | 55th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 54 out of 125 | 57th |
Industry Surgical and Medical Instruments and Apparatus | 51 out of 105 | 51st |
Source: SEC filing on January 29, 2024.
Rosa's colleagues
We found two more compensation records of executives who worked with Dave Rosa at NEUROONE MEDICAL TECHNOLOGIES Corp in 2023.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021